Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-β-dependent pathways

被引:32
作者
Becker, KA
Lu, SL
Dickinson, ES
Dunphy, KA
Mathews, L
Schneider, SS
Jerry, DJ [1 ]
机构
[1] Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA
[2] Univ Massachusetts, Dept Vet & Anim Sci, Paige Lab, Amherst, MA 01003 USA
[3] Baystate Med Ctr, UMass Biomed Res Inst, Springfield, MA 01099 USA
关键词
p53; estrogen; progesterone; TGF-beta; chemoprevention; mammary;
D O I
10.1038/sj.onc.1208787
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA damage normally induces p53 activity, but responses to ionizing radiation in the mammary epithelium vary among developmental stages. The following studies examined the hormones and growth factors that regulate radiation-responsiveness of p53 in mouse mammary epithelium. Immunoreactive p21/WAF1 and TUNEL staining were used as indicators of p53 activity following exposure to ionizing radiation. In ovariectomized mice, radiation-induced accumulation of p21/WAF1 was minimal in the mammary epithelial cells ( < 1%). Systemic injections of estrogen and progesterone (E + P) for 72 h were necessary to recover maximal expression of p21/WAF1 following ionizing radiation (55%). The effects of E + P on radiation-induced p21/WAF1 were p53-dependent as responses were absent in Trp53(-/-) mice. Though hormonal treatments stimulated increases in the proportion of cycling cells (PCNA-positive), this was not directly correlated with p53 activity. Whole organ cultures were used to determine whether E + P act directly upon the mammary gland. Treatment with E + P was sufficient to render p53 responsive to radiation, but TGF-beta-neutralizing antibodies blocked responsiveness. In the absence of E + P, TGF-beta 1 alone did not alter p53 activity. These results demonstrate that estrogen and progesterone together with TGF-beta signaling are necessary for maintenance of p53 activity in the mammary epithelium.
引用
收藏
页码:6345 / 6353
页数:9
相关论文
共 47 条
[11]   ESTROGENIC ACTIVITY OF RU-486 (MIFEPRISTONE) IN RAT UTERUS AND CULTURED UTERINE MYOCYTES [J].
DIBBS, KI ;
SADOVSKY, Y ;
LI, XJ ;
KOIDE, SS ;
ADLER, S ;
FUCHS, AR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (01) :134-140
[12]  
Ewan KB, 2002, CANCER RES, V62, P5627
[13]   Latent transforming growth factor-β activation in mammary gland -: Regulation by ovarian hormones affects ductal and alveolar proliferation [J].
Ewan, KB ;
Shyamala, G ;
Ravani, SA ;
Tang, Y ;
Akhurst, R ;
Wakefield, L ;
Barcellos-Hoff, MH .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (06) :2081-2093
[14]   Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells [J].
Goepfert, TM ;
McCarthy, M ;
Kittrell, FS ;
Stephens, C ;
Ullrich, RL ;
Brinkley, BR ;
Medina, D .
FASEB JOURNAL, 2000, 14 (14) :2221-2229
[15]   Proliferation markers [J].
Iatropoulos, MJ ;
Williams, GM .
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 1996, 48 (2-3) :175-181
[16]   ESTROGENIC ACTIONS OF RU486 IN HORMONE-RESPONSIVE MCF-7 HUMAN BREAST-CANCER CELLS [J].
JENG, MH ;
LANGANFAHEY, SM ;
JORDAN, VC .
ENDOCRINOLOGY, 1993, 132 (06) :2622-2630
[17]   A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development [J].
Jerry, DJ ;
Kittrell, FS ;
Kuperwasser, C ;
Laucirica, R ;
Dickinson, ES ;
Bonilla, PJ ;
Butel, JS ;
Medina, D .
ONCOGENE, 2000, 19 (08) :1052-1058
[18]   Delayed involution of the mammary epithelium in BALB/c-p53null mice [J].
Jerry, DJ ;
Kuperwasser, C ;
Downing, SR ;
Pinkas, J ;
He, C ;
Dickinson, E ;
Marconi, S ;
Naber, SP .
ONCOGENE, 1998, 17 (18) :2305-2312
[19]   A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA [J].
KASTAN, MB ;
ZHAN, QM ;
ELDEIRY, WS ;
CARRIER, F ;
JACKS, T ;
WALSH, WV ;
PLUNKETT, BS ;
VOGELSTEIN, B ;
FORNACE, AJ .
CELL, 1992, 71 (04) :587-597
[20]  
Kuperwasser C, 2000, CANCER RES, V60, P2723